SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/4620ACBB36E94ACE0214FD6896684A574A9B899EEF1BCC5C0D68106111040562C762E51EB97182070210B19D79C15728>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/4620ACBB36E94ACE0214FD6896684A574A9B899EEF1BCC5C0D68106111040562C762E51EB97182070210B19D79C15728
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4620ACBB36E94ACE0214FD6896684A574A9B899EEF1BCC5C0D68106111040562C762E51EB97182070210B19D79C15728
http://www.w3.org/2000/01/rdf-schema#comment
"these data indicate that Nek2 has a pivotal role in breast cancer growth at primary and secondary sites and thus may be an attractive and novel therapeutic target for this disease."
xsd:string
http://purl.uniprot.org/uniprot/#_C1F897199321B67C57C97346E67519D226BF2CB20EA5B3D3E2D7E0B742DD41BB0DF25F7DA5DCCBB1B8B486E3C2C61B6B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/4620ACBB36E94ACE0214FD6896684A574A9B899EEF1BCC5C0D68106111040562C762E51EB97182070210B19D79C15728
http://purl.uniprot.org/uniprot/O35942
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4620ACBB36E94ACE0214FD6896684A574A9B899EEF1BCC5C0D68106111040562C762E51EB97182070210B19D79C15728
http://purl.uniprot.org/uniprot/#_O35942-mappedCitation-23708664
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4620ACBB36E94ACE0214FD6896684A574A9B899EEF1BCC5C0D68106111040562C762E51EB97182070210B19D79C15728